Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-05

Clinical Trial Update: Standard Optimization of Stem Cells in Parkinson's Disease and Atypical Parkinsonism [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update describing a Phase 1/Phase 2 study on standard optimization of stem cells for Parkinson disease and atypical Parkinsonism, currently not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Apeiron Research Center | Conditions: Atypical Parkinsonism, Parkinson Disease (PD) | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING